INSIGHTS REPORT
What $20B in Capital Spend Tells Us About the Future of Surgical Robotics
Surgical robotics is no longer a future play. It’s here, and hospitals are spending big. HANDLE analyzed $20B in real capital spend across U.S. health systems to uncover what’s driving purchases, replacements, and strategy in one of the fastest-growing categories in healthcare.
What You’ll Learn in This Report:
- Which platforms dominate soft tissue, orthopedic, and bronchoscopy procedures
- Why some systems are being replaced before the industry’s expected lifespan
- The 3 commercial strategies that are actually working with health systems in 2025
- What costs often get overlooked—like disposables, service contracts, and training
- How to evaluate surgical robotics beyond clinical outcomes—including staffing, workflows, and long-term capital strategy
